Aktive farmaceutiske ingredienser
| Gestagen og østrogen | |||
| Produktnavn | Specifikation | Godkendt | CAS-nr. |
| Progesteron | CP/EP/USP/JP | CEP/EU-GMP/FDA | 57-83-0 |
| Pregnenolon | In-house |
Kosher | 145-13-1 |
| Medroxyprogesteron Acetat | CP/EP/USP/JP | DMF/GMP | 71-58-9 |
| Megestrolacetat | CP/EP/USP | DMF i gang | 595-33-5 |
| Mifepriston | CP/IP | DMF/GMP | 84371-65-3 |
| Cyproteronacetat | CP/EP/IP/KP | CEP/TGA/EU-GMP | 427-51-0 |
| Levonorgestrel | CP/EP/USP/IP | CEP/GMP | 797-63-7 |
| Norethisteron |
CP/EP/USP/JP |
DMF i gang |
68-22-4 |
| Norethisteronacetat |
EP/USP |
DMF i gang |
51-98-9 |
| Norethisteron Enanthate |
In-house |
Under R&D |
3836-23-5 |
| Drospirenon | EP/USP | DMF | 67392-87-4 |
| Gestodene | CP/EP | DMF/GMP | 60282-87-3 |
| Østradiol | CP/EP/USP/KP | DMF/GMP/WC | 35380-71-3 |
| Estriol | CP/EP/USP | Under R&D | 50-27- 1 |
| Ethinylestradiol | CP/EP/USP | GMP | 57-63-6 |
| Østradiol Valerat | CP/EP/USP/KP | DMF | 979-32-8 |
| Østradiol Cypionate |
USP | DMF i gang |
313-06-4 |
| Promestriene |
In-house |
Under R&D |
39219-28-8 |
| Tibolone | CP/EP | DMF/GMP | 5630-53-5 |
| Dienogest | EP | CEP/GMP | 65928-58-7 |
| Fulvestrant | EP/USP | Under R&D | 129453-61-8 |
| Exemestan | CP/EP/USP | Under R&D | 107868-30-4 |
| androgen | |||
| Produktnavn | Specifikation | Godkendt | CAS-nr. |
| Finasteride | CP/EP/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
| Dutasteride | EP/USP | CEP/FDA | 164656-23-9 |
| Abirateronacetat | CP/USP | DMF/GMP/WC | 154229-18-2 |
| Darolutamid |
In-house |
Under R&D |
1297538-32-9 |
| Testosteron | CP/EP/USP | CEP/FDA/WC | 58-22-0 |
| Testosteron undecanoat | CP | DMF/WC | 5949-44-0 |
| Testosteron Cypionate | USP | DMF | 58-20-8 |
| Testosteron Enanthate |
USP/JP | Under R&D |
315-37-7 |
| Testosteron propionat |
CP/EP/USP/JP |
Under R&D |
57-85-2 |
| DHEA | FP/In-house | DMF/WC/Kosher | 53-43-0 |
| Clascoterone | In-house | DMF i gang | 19608-29-8 |
| Kortikalt hormon | |||
| Produktnavn | Specifikation | Godkendt | CAS-nr. |
| Budesonid | CP/EP/USP/JP | CEP/FDA/GMP | 51333-22-3 |
| Desonid | CP/USP | DMF/GMP | 638-94-8 |
| Eplerenon | EP | CEP i gang | 107724-20-9 |
| Methylprednisolon | CP/EP/USP/JP | DMF/GMP | 83-43-2 |
| Methylprednisolon Hemisuccinat | CP/EP/USP | DMF/GMP | 2921-57-5 |
| Fluticasonpropionat | CP/EP/USP | DMF | 80474-14-2 |
| Flutikasonfuroat | CP/EP | DMF i gang | 397864-44-7 |
| Mometasonfuroat |
CP/EP/USP |
DMF i gang |
Vandfri (83919-23-7) Monohydrat (141646-00-6) |
| Deflazacort |
In-house |
Under R&D |
14484-47-0 |
| Andre | |||
| Produktnavn | Specifikation | Godkendt | CAS-nr. |
| Oxcarbazepin | CP/EP/USP/IP | CEP/FDA/GMP | 28721-07-5 |
| Eslicarbazepinacetat | CP/USP | DMF | 236395-14-5 |
| Ganciclovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
| Valganciclovir Hydrochlorid | USP/EP | CEP i gang | 175865-59-5 |
| Oseltamivir fosfat | CP/EP/USP | DMF | 204255-11-8 |
| Baloxavir Marboxil | In-house | Under R&D | 1985606-14-1 |
| Revefenacin | In-house | DMF | 864750-70-9 |
| Mirabegron | CP/EP | DMF | 223673-61-8 |
| Vibegron |
In-house |
Under R&D |
1190389-15-1 |
| Escitalopram Oxalat | CP/EP/USP | DMF i gang | 219861-08-2 |
| Citalopram Hydrobromid |
CP/EP/USP |
DMF i gang |
59729-32-7 |
| Cariprazin hydrochlorid | In-house | DMF | 1083076-69-0 |
| Lasmiditansuccinat | In-house | DMF | 439239-92-6 |
| Luliconazol | In-house | DMF | 187164-19-8 |
| Nintedanib Esylate |
In-house |
FDA/DMF/WC |
656247-18-6 |
| Apalutami | In-house | DMF | 956104-40-8 |
| Tadalafil | CP/EP/USP | Under R&D | 171596-29-5 |
| Relugolix | In-house | DMF i gang | 737789-87-6 |
| Ruxolitinib fosfat |
In-house |
DMF i gang |
1092939-17-7 |
| Abemaciclib |
In-house |
Under R&D |
1231929-97-7 |
| Phloroglucinol | CP/EP | DMF | 108-73-6 |
| 1,3,5-trimethoxybenzen |
CP/In-house |
GMP |
621-23-8 |
| Ursodeoxycholsyre | EP/USP/JP | Under R&D | 128-13-2 |
| Tauroursodeoxycholsyre |
In-house |
Under R&D |
14605-22-2 |
| Kolesterol |
CP/EP/USP/JP |
Under R&D |
57-88-5 |
| Omega-3-syre ethylethere 90 |
EP/USP |
DMF i gang |
—— |
| Mellemkædede triglycerider |
CP/USP/EP |
DMF |
—— |
| Benzalkoniumchlorid |
USP/EP/JP |
CEP i gang |
8001-54-5 |
| Olivenolie (til injektion) |
CP/USP/EP/JP |
DMF i gang |
8001-25-0 |
| Ægfosfolipider (til injektion) |
CP/USP/EP |
DMF |
93685-90-6 |
| Mellemmåltid |
In-house |
DMF i gang |
203787-91-1 |
Abiraterone Acetate har CP,USP specifikationer. DMF, toilet til rådighed.
Drospirenon har EP,USP specifikationer. DMF godkendt.
Medroxyprogesteronacetat har USPãEPã IPãJP og KP. DMF, GMP er tilgængelig.
Oxcarbazepin har CP, EP og USP specifikationer. CEP og DMF tilgængelige, GMP godkendt.
Ganciclovir har CP,EP, USP-specifikation.DMF og GMP godkendt.
Nintedanib Esylate har in-house specifikation.DMF tilgængelig.